Manufacturer: Deus Medical, Europe
Pharmaceutical name: Bremelanotide
Pack: 1 vial (10 mg)
PT-141 (Bremelanotide) is a medication utilized for the treatment of hypoactive sexual desire disorder (HSDD). It is available as injections of 10mg per vial, containing 10mg of Bremelanotide along with excipients.
Bremelanotide Mechanism of Action:
Bremelanotide functions as a melanocortin receptor agonist. It targets M1 to M5 receptors to enhance libido in individuals without existing medical conditions.
Bremelanotide Dosage:
A single injection is administered prior to sexual activity.
Bremelanotide Side Effects:
Possible side effects include nausea and vomiting, cough, reactions at the injection site, and headache.
Bremelanotide Interactions:
May interact with COX inhibitors and Naltrexone.